Enliven Therapeutics, Inc. (ELVN) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Enliven Therapeutics, Inc. (ELVN) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

ELVN Income Statement

Enliven Therapeutics, Inc. (ELVN) annual income statement — 9-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	0	46K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	-46K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	100%	100%	100%	-
Operating Expenses	36.05M	37.21M	27.82M	34.24M	25.1M	28.58M	31.69M	26.9M	27.07M	24.6M	25.99M	22.73M	24.25M	20.13M	16.42M	10.16M	10.93M	9.02M	8.68M	8.39M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	8.02M	8.21M	7.14M	13.04M	6.87M	7.09M	6.8M	6.17M	5.81M	5.78M	6.02M	4.82M	3.34M	3.65M	4.54M	1.97M	3.1M	1.08M	1.62M	1.53M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	28.02M	29M	20.69M	21.25M	18.23M	21.49M	24.89M	20.72M	21.26M	18.83M	19.97M	17.91M	19.61M	15.18M	11.88M	8.2M	7.83M	7.94M	7.06M	6.86M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	1000K	1000K	0	0	0	0	0	0
Operating Income	-36.05M	-37.21M	-27.82M	-34.28M	-25.1M	-28.58M	-31.69M	-26.9M	-27.07M	-24.6M	-25.99M	-22.73M	-24.25M	-20.13M	-16.42M	-10.16M	-10.93M	-9.02M	-8.68M	-8.39M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-43.63%	-30.17%	12.21%	-27.47%	7.29%	-16.18%	-21.96%	-18.33%	-11.63%	-22.2%	-58.28%	-123.64%	-121.77%	-123.31%	-89.19%	-21.06%	19.95%	31.54%	15.58%	27.32%
EBITDA	-36.03M	-37.2M	-27.81M	-34.24M	-25.03M	-28.5M	-31.62M	-26.82M	-26.99M	-24.52M	-25.91M	-22.65M	-24.17M	-20.06M	-16.35M	-10.1M	-10.87M	-8.96M	-8.64M	-8.36M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-43.93%	-30.52%	12.05%	-27.68%	7.24%	-16.22%	-22.04%	-18.39%	-11.66%	-22.26%	-58.45%	-124.29%	-122.27%	-123.78%	-89.27%	-20.77%	20.25%	31.8%	15.76%	27.46%
D&A (Non-Cash Add-back)	13K	7K	14K	46K	62K	81K	74K	80K	80K	78K	79K	78K	78K	74K	67K	64K	60K	52K	39K	33K
EBIT	-27.7M	-32.48M	-23.63M	-29.67M	-20.15M	-25.34M	-28.54M	-23.18M	-23.16M	-19.72M	-22.74M	-22.73M	-24.25M	-20.13M	-16.42M	-10.16M	-10.93M	-9.02M	-8.68M	-8.39M
Net Interest Income	8.35M	4.72M	4.2M	4.62M	4.95M	3.25M	3.2M	3.72M	3.84M	4.09M	3.25M	3.37M	3.49M	3.41M	1.69M	613K	380K	127K	9K	3K
Interest Income	8.35M	4.73M	4.2M	4.62M	4.95M	3.25M	3.2M	3.72M	3.84M	4.09M	3.25M	3.37M	3.49M	3.41M	1.69M	613K	380K	127K	9K	3K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	8.34M	4.72M	4.2M	4.62M	4.95M	3.25M	3.15M	3.72M	3.91M	4.88M	3.25M	3.36M	3.48M	3.41M	1.69M	613K	380K	127K	9K	3K
Pretax Income	-27.7M	-32.48M	-23.63M	-29.67M	-20.15M	-25.34M	-28.54M	-23.18M	-23.16M	-19.72M	-22.74M	-19.37M	-20.77M	-16.72M	-14.72M	-9.55M	-10.55M	-8.89M	-8.67M	-8.39M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	232K	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	-1.18%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-27.7M	-32.48M	-23.63M	-29.67M	-20.15M	-25.34M	-28.54M	-23.18M	-23.16M	-19.95M	-22.74M	-19.37M	-20.77M	-16.72M	-14.72M	-9.55M	-10.55M	-8.89M	-8.67M	-8.39M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-37.5%	-28.22%	17.23%	-27.99%	12.99%	-26.99%	-25.53%	-19.67%	-11.49%	-19.31%	-54.43%	-102.83%	-96.79%	-88.11%	-69.85%	-13.8%	22.66%	32.46%	15.48%	27.14%
Net Income (Continuing)	-27.7M	-32.48M	-23.63M	-29.67M	-20.15M	-25.34M	-28.54M	-23.18M	-23.16M	-19.95M	-22.74M	-19.37M	-20.77M	-16.72M	-14.72M	-9.55M	-10.55M	-8.89M	-8.67M	-8.39M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.36	-0.49	-0.38	-0.45	-0.32	-0.49	-0.57	-0.46	-0.48	-0.41	-0.54	-0.47	-0.51	-0.41	-0.80	4.90	-0.70	-1.74	-2.23	-2.18
EPS Growth %	-12.5%	0%	33.33%	2.17%	33.33%	-19.51%	-5.56%	2.13%	5.88%	0%	32.5%	-109.59%	27.14%	76.44%	64.13%	324.77%	68.04%	41.41%	4.29%	17.11%
EPS (Basic)	-0.36	-0.49	-0.38	-0.45	-0.32	-0.49	-0.57	-0.46	-0.48	-0.41	-0.54	-0.47	-0.51	-0.41	-0.80	4.90	-0.70	-1.74	-2.23	-2.18
Diluted Shares Outstanding	77.98M	66.17M	62.8M	56.66M	62.09M	52.11M	50.05M	49.86M	48.27M	48.08M	42.05M	41.13M	41.03M	40.96M	18.52M	6.57M	6.57M	6.57M	6.57M	6.57M
Basic Shares Outstanding	77.98M	66.17M	62.8M	56.66M	62.09M	52.11M	50.05M	49.86M	48.27M	48.08M	42.05M	41.13M	41.03M	40.96M	18.52M	6.57M	6.57M	6.57M	6.57M	6.57M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-